ArticlePharmacoEconomics2021

A Comparison of the SF-6Dv2 and SF-6D UK Utility Values in a Mixed Patient and Healthy Population.

Emily McDool et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.